PUBLICATIONS FDA Decisions Expected: August 2025 Your monthly synopsis of new drugs expected to hit the market July 16, 2025 Drug pipeline for August 2025 At Prime Therapeutics (Prime), we have...

Support your members with diabetes and obesity We help members navigate the challenges of diabetes and obesity with our holistic, customized approach to care. Breadcrumb Home Our solutions...

Academy of Managed Care Pharmacy (AMCP)'s Annual Meeting gathers thousands of health plan, pharmacy benefit management and biopharmaceutical experts to help define the future of managed care pharmacy.

Experience pharmacy solutions built for you Get holistic, people-centered solutions that help you save money while delivering a better member experience. Breadcrumb Home Who we are About us...

From research posters and education sessions to the Pharmacy Friends podcast, Prime has you covered on the latest managed care pharmacy insights

Prime’s industry-leading research on GLP-1s was recognized at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting in Houston

Forbes

Read Drug Approvals Monthly Update: March 2024 Critical updates in an ever-changing environment Drug Approval Update Specialty New drugs 3/13/2024 Tevimbra™ (tislelizumab-jsgr) Tevimbra, a...

U.S. News & World Report

Specialty Pharmacy Continuum

Forbes

Publications Clinical Highlights: November 2024 Your monthly source for drug information highlights. November 27, 2024 Weight Management Corner: catch up on recent publications and study findings...

Prime Therapeutics Report shares more about single-treatment gene therapies and proper management

Gene therapy harnesses the body’s capacity to heal itself

Cover image for The evolution of GLP-1s Developing a holistic, individualized strategy to capitalize on opportunities and outcomes Prime Therapeutics /the-evolution-of-glp-1s About Prime...

publications Metabolic dysfunction–associated steatohepatitis (MASH) A new era in liver health: Treatment innovation, payer strategy, and pipeline momentum August 15, 2025 Prime Therapeutics’...

New report explores traditional, specialty therapy trend impact to employers

From next-gen CFTR modulators to gene therapy and real-world drug impact, cystic fibrosis care is constantly evolving. Maryam Tabatabai, PharmD, of Prime Therapeutics, explains how innovative...

Publications Clinical Highlights: February 2025 Your monthly source for drug information highlights. February 28, 2025 Trending topics The annual report Cancer statistics, 2025 from the American...

cover image for Summer 2025 Issue: Clinical Insights – MASH A new era in liver health: Treatment innovation, payer strategy, and pipeline momentum Prime Therapeutics...